CSIMarket Company Name, Ticker, Customers, else..
 
Painreform Ltd  (NASDAQ: PRFX)
Other Ticker:  
 
 
Price: $1.8600 $-0.11 -5.584%
Day's High: $1.94 Week Perf: -5.58 %
Day's Low: $ 1.83 30 Day Perf: -3.12 %
Volume (M): 41 52 Wk High: $ 16.63
Volume (M$): $ 77 52 Wk Avg: $1.76
Open: $1.94 52 Wk Low: $0.20



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 0
 Employees -
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -15
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 0

Painreform Ltd
Painreform Ltd is a biopharmaceutical company based in Israel. The company specializes in developing novel, non-opioid pain management treatments. They focus on utilizing their proprietary extended-release platform technology to create improved drug formulations for the treatment of acute and chronic pain. Painreform aims to provide effective and safer alternatives to traditional opioid-based pain medications, which can be addictive and have numerous side effects. They are actively engaged in clinical trials and collaborations with other pharmaceutical companies to advance their innovative pain management solutions.


   Company Address: 65 Yigal Alon St. Tel Aviv 6744316
   Company Phone Number:    Stock Exchange / Ticker: NASDAQ PRFX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ELTP   -1.03%    
NTRB   -8.22%    
• View Complete Report
   



Merger and Acquisition

PainReforms Bold Leap: Merging Pharmaceuticals with AI-Powered Solar Analytics

Published Wed, Mar 5 2025 4:00 PM UTC

In a groundbreaking move that sets the stage for expansive growth, PainReform Ltd (NASDAQ: PRFX) has announced its strategic acquisition of DeepSolar, a pioneering company specializing in AI-driven solar analytics. This unexpected diversion from PainReform s core pharmaceutical focus has analysts buzzing about the significant implications for the company s future. Key Facts ...
Merger and Acquisition

PainReform Partners with DeepSolar: A Unique Cross-Industry Opportunity in Renewable Energy Expansion,

Published Tue, Feb 18 2025 1:30 PM UTC

DeepSolar s Strategic Leap: Merging Solar Analytics with AI and PharmaceuticalsIn a remarkable intersection of technological innovation and renewable energy, DeepSolar has positioned itself at the forefront of a burgeoning market following its recent merger with PainReform. Announced on March 5, 2025, this strategic alliance is set to redefine customer engagement in the sol...
Clinical Study

Turning the Tide Will PainReform?s PRF-110 Redefine Post-Surgical Pain Management Amid Financial Struggles,

Published Fri, Dec 27 2024 4:09 PM UTC

In the realm of pharmaceutical innovation, PainReform Ltd. stands out as a clinical-stage specialty pharmaceutical company dedicated to reformulating established therapeutics for enhanced therapeutic outcomes. Recently, the company provided an update on its ongoing Phase 3 clinical trial assessing the efficacy of PRF-110 in managing post-surgical pain for patients undergoing...
Product Service News

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial

Published Wed, Nov 20 2024 1:30 PM UTC

PainReform Reveals Promising Topline Data for PRF-110 in Phase 3 Clinical Trial Tel Aviv, Israel PainReform Ltd. (Nasdaq: PRFX), a clinical-stage pharmaceutical company focused on the reformulation of established therapeutics, has recently announced the receipt of preliminary topline data from the Phase 3 clinical trial assessing PRF-110 for post-surgical pain management...
Stock Market Announcement

PainReform Ltd Faces Continued Nasdaq Compliance Struggles Amid Ongoing Financial Challenges

Published Thu, Nov 7 2024 10:00 PM UTC

An Ongoing Battle for Compliance: PainReform Ltd?s Struggles on the Nasdaq ExchangeAs of November 7, 2024, PainReform Ltd. (NASDAQ: PRFX), a clinical-stage specialty pharmaceutical company based in Tel Aviv, has encountered critical hurdles in maintaining its listing on the Nasdaq Stock Market. The company received a notification from the Nasdaq Listing Qualifications Depart...









Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com